Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine in Cervical Cancer and Renal Disease
NCT03101995Phase 2Recruiting
- Sponsor
- Instituto Nacional de Cancerología
- Start
- Jan 2018
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in Cervical Cancer (CC), sponsored by Instituto Nacional de Cancerología. Started Jan 2018; status: recruiting.
02
Drugs
gemcitabine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT03101995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03101995.